According to a report, there is a trend correlating higher SETDB1 expression with an advanced pathological state in NSCLC patients [11], which coincides with the situation of SETDB1 amplification in ADC [128]. This evidence concerns the gene SETDB1 and non-small cell lung carcinoma.